Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes
- PMID: 39178160
- DOI: 10.1097/QAD.0000000000003996
Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes
Abstract
Objective: Individuals with HIV experience an increased risk of lymphoma, making this an important cause of death among people with HIV. Nevertheless, little is known regarding the underlying genetic aberrations, which we therefore set out to characterize.
Design: We conducted next-generation panel sequencing to explore the mutational status of diagnostic lymphoma biopsies from 18 patients diagnosed with lymphoma secondary to HIV infection.
Methods: Ion Torrent next-generation sequencing was performed with an AmpliSeq panel on diagnostic lymphoma biopsies from HIV-associated B-cell lymphomas ( n = 18), comprising diffuse large B-cell lymphoma ( n = 9), classic Hodgkin lymphoma ( n = 6), Burkitt lymphoma ( n = 2), follicular lymphoma ( n = 1), and marginal zone lymphoma ( n = 1). The panel comprised 69 lymphoid and/or myeloid-relevant genes, in which either the entire coding sequence or a hotspot region was sequenced.
Results: Among the 18 lymphomas, we detected 213 variants. The number of detected mutations ranged from 4 to 41 per tumor distributed among 42 genes, including both exonic and intronic regions. The most frequently mutated genes included KMT2D (67%), TNFAIP3 (50%), and TP53 (61%). Notably, no gene was found to harbor variants across all the HIV-associated lymphomas, nor did we find subtype-specific variants. While some variants were shared among patients, most were unique to the individual patient and were often not reported as malignant genetic variants in databases.
Conclusion: Our findings demonstrate genetic heterogeneity across histological subtypes of HIV-associated lymphomas and thus help elucidate the genetics and pathophysiological mechanisms underlying the disease.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Yarchoan R, Uldrick TS. HIV-associated cancers and related diseases . N Engl J Med 2018; 378:1029–1041.
-
- Vandenhende M-A, Roussillon C, Henard S, Morlat P, Oksenhendler E, Aumaitre H, et al. Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2000 . PLoS One 2015; 10:e0129550.
-
- Noy A. Optimizing treatment of HIV-associated lymphoma . Blood 2019; 134:1385–1394.
-
- Kim Y, Kim SW, Chang HH, Kwon KT, Bae S, Hwang S. Trends of cause of death among human immunodeficiency virus patients and the impact of low CD4 counts on diagnosis to death: a retrospective cohort study . J Korean Med Sci 2020; 35:e355.
-
- Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study . AIDS 2014; 28:2313–2318.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
